期刊
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
卷 12, 期 3, 页码 357-366出版社
CANADIAN SOC PHARMACEUTICAL SCIENCES
DOI: 10.18433/J34G69
关键词
-
资金
- Roche Foundation
- Instituto de Salud Carlos III [CP06/00067]
- Ministerio de Sanidad y Consumo [FIS PI070768, FIS 08/1085]
- ISCIII-RETIC [RD06/0020/0097]
P-glycoprotein (Pgp), a protein codified by Multi Drug Resistance (MDR1) gene, has a detoxifying function and might influence the toxicity and pharmacokinetics and pharmacodynamics of drugs. Sampling strategies to improve Pgp studies could be useful to optimize the sensitivity and the reproducibility of efflux assays. This study aimed to compare Pgp expression and efflux activity by measuring Rhodamine123 (Rh123) retention in lymphocytes stored under different conditions, in order to evaluate the potential utility of any of the storing conditions in Pgp functionality. Our results show no change in protein expression of Pgp by confocal studies and Western blotting, nor changes at the mRNA level (qRT-PCR). No differences in Rh123 efflux by Pgp activity assays were found between fresh and frozen lymphocytes after 24 hours of blood extraction, using either of the two Pgp specific inhibitors (VP and PSC833). Different working conditions in the 24 hours post blood extraction do not affect Rh123 efflux. These results allow standardization of Pgp activity measurement in different individuals with different timing of blood sampling and in different geographic areas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据